Therapeutics News

Switching to preservative-free topical formulations for glaucoma may improve patient adherence to treatment and improve symptoms and signs of ocular surface disease, according to a study published in Clinical Ophthalmology.

SAN DIEGO — Results from a pilot study showed that low-dose doxycycline may hold promise as an adjunct treatment for IOP reduction, according to a poster presented at Academy 2022.

SAN DIEGO — Patients with stage 1 neurotrophic keratitis experienced significant improvements in corneal sensitivity and best-corrected visual acuity after an 8-week course of Oxervate, according to a study presented at Academy 2022.

SAN DIEGO — Phentolamine with and without low-dose pilocarpine significantly improved distance-corrected near visual acuity without compromising distance vision, according to a poster presented at Academy 2022.

SAN DIEGO — Oral drug candidate APX3330 showed a “favorable safety and tolerability profile” in patients with diabetes and diabetic retinopathy, according to research presented in a poster at Academy 2022.

MILAN — Caring for patients in conflict zones, Ukrainian ophthalmologists work under constant pressure and face multiple challenges.

Santen and UBE announced the FDA approval of Omlonti for the reduction of elevated IOP in patients with primary open-angle glaucoma or ocular hypertension.

LAS VEGAS – Optometrists should be aware of the current concern for overprescribing of opiates, Marc D. Myers, Coatesville VA Medical Center, said at Vision Expo West.

MONTEREY, Calif. — The aqueous humor is important for diagnosis, prognosis and objective monitoring of treatment response in cases of retinoblastoma, Jesse L. Berry, MD, told colleagues here.

MONTEREY, Calif. — Interferon alpha-2b, 5-fluorouracil and mitomycin C can all be used topically for conjunctival tumors, Lauren A. Dalvin, MD, said at the Women in Ophthalmology Summer Symposium.